Literature DB >> 5301735

Rapidity and magnitude of antibody response to duck-embryo rabies vaccine administered as a pre-exposure regimen.

P R Schnurrenberger, G R Anderson, J H Russell.   

Abstract

Rabies virus appears in the central nervous system within hours after it is introduced peripherally. It has been suggested that rapidity of appearance is an important factor in providing immunity against rabies. Since pre-exposure vaccination of man against this disease is performed in high-risk occupational groups, it is important to know the time-interval between administration of vaccine and appearance of antibody. This report shows that persons who received a booster inoculation of duck-embryo rabies vaccine 6 months after a pre-exposure course of 3 sensitizing intradermal doses of the same vaccine responded rapidly with the production of demonstrable antibody. That response was not assured if the person had failed to develop demonstrable antibody after the primary series. Antibody response to the booster occurred 3-8 days earlier than the appearance of antibody in persons who, in earlier studies, had received an intensive primary course of 14-21 subcutaneous doses of vaccine.The authors suggest that all persons who have received a primary course of rabies immunization should be tested for rabies antibody to determine whether the antibody-forming mechanism has been properly conditioned to respond to a booster injection in the event of subsequent exposure to rabies virus.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5301735      PMCID: PMC2554371     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  PATHOGENESIS OF RABIES.

Authors:  D J DEAN; W M EVANS; R C MCCLURE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

2.  AVIAN EMBRYO RABIES IMMUNIZATION. 3. OPTIMAL SITE AND TIMING OF INTRADERMAL INOCULATIONS IN PRE-EXPOSURE REGIMENS.

Authors:  P R SCHNURRENBERGER; W J BASHE; J H HELWIG
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

3.  A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs.

Authors:  F B PECK; H M POWELL; C G CULBERTSON
Journal:  J Lab Clin Med       Date:  1955-05

4.  Pre-exposure rabies immunization in man using duck-embryo vaccine.

Authors:  W H DIETERICH; D F SHELTON; E P JENEVEIN
Journal:  J Am Vet Med Assoc       Date:  1961-11-01       Impact factor: 1.936

5.  Primary antirabies immunization of man with HEP flury virus vaccine.

Authors:  J M RUEGSEGGER; J BLACK; G R SHARPLESS
Journal:  Am J Public Health Nations Health       Date:  1961-05

6.  Avian embryo rabies immunization. II. A comparison of the antigenicity of high egg-passage and duck-embryo vaccines administered intradermally in man.

Authors:  P R SCHNURRENBERGER; G R ANDERSON; J H RUSSELL; F H WENTWORTH
Journal:  Am J Hyg       Date:  1961-07

7.  Prophylaxis against rabies in humans.

Authors:  J P FOX
Journal:  Ann N Y Acad Sci       Date:  1958-06-03       Impact factor: 5.691

8.  Antiserum in the prophylaxis of rabies.

Authors:  K HABEL
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

9.  Avianized rabies virus vaccination in man.

Authors:  M P SCHWAB; J P FOX; D P CONWELL; T A ROBINSON
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

10.  Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).

Authors:  C G CULBERTSON; F B PECK; H M POWELL
Journal:  J Am Med Assoc       Date:  1956-12-08
View more
  2 in total

1.  Human pre-exposure rabies immunization with suckling mouse brain vaccine.

Authors:  E Fuenzalida
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

Review 2.  Four Thousand Years of Concepts Relating to Rabies in Animals and Humans, Its Prevention and Its Cure.

Authors:  Arnaud Tarantola
Journal:  Trop Med Infect Dis       Date:  2017-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.